1. Home
  2. VKTX vs BC Comparison

VKTX vs BC Comparison

Compare VKTX & BC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • BC
  • Stock Information
  • Founded
  • VKTX 2012
  • BC 1845
  • Country
  • VKTX United States
  • BC United States
  • Employees
  • VKTX N/A
  • BC N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • BC Homebuilding
  • Sector
  • VKTX Health Care
  • BC Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • BC Nasdaq
  • Market Cap
  • VKTX 4.6B
  • BC 4.9B
  • IPO Year
  • VKTX 2015
  • BC N/A
  • Fundamental
  • Price
  • VKTX $42.25
  • BC $66.71
  • Analyst Decision
  • VKTX Strong Buy
  • BC Buy
  • Analyst Count
  • VKTX 12
  • BC 14
  • Target Price
  • VKTX $106.75
  • BC $88.31
  • AVG Volume (30 Days)
  • VKTX 3.7M
  • BC 617.3K
  • Earning Date
  • VKTX 02-05-2025
  • BC 01-30-2025
  • Dividend Yield
  • VKTX N/A
  • BC 2.52%
  • EPS Growth
  • VKTX N/A
  • BC N/A
  • EPS
  • VKTX N/A
  • BC 4.01
  • Revenue
  • VKTX N/A
  • BC $5,444,100,000.00
  • Revenue This Year
  • VKTX N/A
  • BC N/A
  • Revenue Next Year
  • VKTX N/A
  • BC $3.94
  • P/E Ratio
  • VKTX N/A
  • BC $16.64
  • Revenue Growth
  • VKTX N/A
  • BC N/A
  • 52 Week Low
  • VKTX $17.23
  • BC $66.41
  • 52 Week High
  • VKTX $99.41
  • BC $99.68
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 33.93
  • BC 21.72
  • Support Level
  • VKTX $37.80
  • BC $76.45
  • Resistance Level
  • VKTX $48.55
  • BC $73.30
  • Average True Range (ATR)
  • VKTX 2.54
  • BC 2.34
  • MACD
  • VKTX -0.45
  • BC -1.14
  • Stochastic Oscillator
  • VKTX 30.11
  • BC 2.16

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About BC Brunswick Corporation

Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns numerous Freedom Boat Club (shared ownership) locations as well as Boateka, which facilitates transactions in the used boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.

Share on Social Networks: